Once a year we put the investors in a room by themselves. No startups. No pitches. No slides.
Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening.
It's invitation-only and space is limited
